• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Insulin Delivery Systems Market Forecast to 2014 Product Image

Insulin Delivery Systems Market Forecast to 2014

  • Published: February 2012
  • Region: Global
  • 90 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • Becton Dickinson
  • Eli Lilly
  • F. Hoffmann La Roche
  • Medtronic
  • Novo Nordisk
  • Sanofi Aventis
  • MORE

The global medical fraternity is alarmed at the rate at which the diabetic population has been increasing worldwide. It is expected that the number of diabetic patients in the world will reach around 552 Million by 2030. With such startlingly constant growth, the demand for diabetes solutions is increasing exceptionally across the globe and has cascading effects on testing equipment and delivery devices market. According to our latest research report, the insulin delivery system market is currently characterized by the emergence of new drug delivery devices, and this trend is likely to continue in the coming few years.

Our recent research “Insulin Delivery Systems Market Forecast to 2014”, states that manufacturers and service providers are recognizing and catering to the special needs of diabetics. As per our estimations, the global insulin delivery systems market will grow at a CAGR of around 8% during 2012-2014. The insulin delivery systems include insulin syringes, pens, pumps and jet injectors. According to our study, insulin syringes and pens dominate the global insulin delivery systems market. Besides, market penetration of both insulin pumps and needle-free READ MORE >

1. Analyst View

2. Research Methodology

3. Global Diabetes Drug Market Overview

4. Key Market Drivers

5. Global Insulin Delivery Devices Market Overview
5.1 India
5.1.1 Prevalence
5.1.2 Market Analysis
5.2 China
5.2.1 Prevalence
5.2.2 Market Analysis
5.3 US
5.3.1 Prevalence
5.3.2 Market Analysis
5.4 Russia
5.4.1 Prevalence
5.4.2 Market Analysis
5.5 Brazil
5.5.1 Prevalence
5.5.2 Market Analysis

6. Insulin Delivery Devices
6.1 Insulin Pens
6.1.1 Mechanism and Technologies
6.1.2 Pros and Cons
6.1.3 Market Analysis
6.1.4 Key Players and Products
6.2 Insulin Pumps
6.2.1 Mechanism and Technologies
6.2.2 Pros and Cons
6.2.3 Market Analysis
6.2.4 Key Players and Products
6.3 Insulin Syringes
6.3.1 Mechanism and Technology
6.3.2 Pros and Cons
6.3.3 Market Analysis
6.3.4 Key Players and Products
6.4 Insulin Jet Injectors
6.4.1 Mechanism and Technologies
6.4.2 Pros and Cons
6.4.3 Market Analysis
6.4.4 Key Players and Products

7. Emerging Devices
7.1 Implantable Insulin Pumps
7.2 Insulin Inhalers
7.3 Oral Insulin/Insulin Pill
7.4 Vaccines
7.5 MEMS Technology
7.6 Islet Cell Transplantation
7.7 Insulin Patch
7.8 Insulin Patch Pump

8. Key Players
8.1 Novo Nordisk
8.2 Eli Lilly
8.3 Medtronic
8.4 Becton Dickinson
8.5 Sanofi Aventis
8.6 F. Hoffmann La Roche

List of Tables

Table 3-1: Global - Diabetic Population of Top 10 Countries (Million), 2011 & 2030
Table 5-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2011 & 2030
Table 5-2: China - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 5-3: US - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 5-4: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 5-5: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 6-1: Global - Share of Players in Prefilled Insulin Pen Market (2010)
Table 6-2: Global - Key Insulin Pen Products by Company
Table 6-3: Global - Key Insulin Syringes Product by Manufacturer

List of Charts

Figure 3-1: Global - Number of Diabetic Patients (Million), 2011 & 2030
Figure 3-2: Global - Healthcare Expenditure on Diabetes (Billion US$), 2011 & 2030
Figure 5-1: Global - Insulin Delivery Devices Market (Billion US$), 2010-2014
Figure 5-2: India - Insulin Market (Million US$), 2010 & 2015
Figure 5-3: India - Share of Key Players in Insulin Market (2010)
Figure 5-4: China - Insulin Syringes Market (Million US$), 2010-2014
Figure 5-5: China - Insulin Pump Market (Million US$), 2010-2014
Figure 5-6: China - Insulin Pen Market (Million US$), 2010-2014
Figure 5-7: China - Share of Key Players in Modern Insulin Market (2010)
Figure 5-8: US - Insulin Pumps Market (Million US$), 2010-2014
Figure 5-9: US - Insulin Pen Market (Million US$), 2010-2014
Figure 5-10: US - Insulin Syringes Market (Million US$), 2010-2014
Figure 5-11: US - Insulin Jet Injectors Market (Million US$), 2010-2014
Figure 5-12: US - Share of Key Players in Modern Insulin Market (2010)
Figure 5-13: Russia - Insulin Market (Million US$), 2009-2011
Figure 5-14: Russia - Share of Key Players in Insulin Market (2010)
Figure 5-15: Brazil - Insulin Market (Million US$), 2010-2014
Figure 5-16: Brazil - Share of Novo Nordisk in Insulin Market (2010)
Figure 6-1: Global - Insulin Pen Market (Billion US$), 2010-2014
Figure 6-2: Global - Insulin Pump Market (Billion US$), 2010-2014
Figure 6-3: Global - Share of Medtronic in Insulin Pumps Market (2010)
Figure 6-4: Global - Insulin Syringes Market (Billion US$), 2010-2014
Figure 6-5: Global - Insulin Jet Injectors Market (Million US$), 2010-2014

- Novo Nordisk
- Eli Lilly
- Medtronic
- Becton Dickinson
- Sanofi Aventis
- F. Hoffmann La Roche

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos